2020
DOI: 10.21203/rs.3.rs-29855/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Leukopenia of Asymptomatic COVID-19 Infections under 18 Years Old in Recovery Stage

Abstract: Background In December, 2019, a type of novel coronavirus which was designated novel coronavirus 2019 (2019-nCoV) by World Health Organization (WHO) occurred in Wuhan, Hubei, China. The epidemiological and clinical characteristics of those patients under 18 years old in the recovery stage are limited. To compare the difference of epidemiological and clinical characteristics of COVID-19 involving 25 patients under 18 years old in recovery stage between confirmed and asymptomatic infections.Methods Retrospective… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 19 publications
(9 reference statements)
0
0
0
Order By: Relevance
“…At presentation, the median level of white blood cell (WBC) counts was significantly lower among patients in ICU (p ¼ 0:0448) (Table 3). This may be due to viral erosion that results in direct inflammation and infection and consequently, excessive destruction of WBCs [36]. This is in agreement with previous studies reporting an association between decreased levels of WBCs in COVID-19 patients at presentation and disease severity and adverse outcomes [9,37,38].…”
Section: Laboratory Biomarkers and Cytokines Measurementsupporting
confidence: 91%
“…At presentation, the median level of white blood cell (WBC) counts was significantly lower among patients in ICU (p ¼ 0:0448) (Table 3). This may be due to viral erosion that results in direct inflammation and infection and consequently, excessive destruction of WBCs [36]. This is in agreement with previous studies reporting an association between decreased levels of WBCs in COVID-19 patients at presentation and disease severity and adverse outcomes [9,37,38].…”
Section: Laboratory Biomarkers and Cytokines Measurementsupporting
confidence: 91%